Allworth Financial’s Enanta Pharmaceuticals ENTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.72K | Buy |
+228
| New | +$1.72K | ﹤0.01% | 3765 |
|
|
2024
Q2 | – | Sell |
-86
| Closed | -$1.5K | – | 3720 |
|
|
2024
Q1 | $1.5K | Buy |
+86
| New | +$1.5K | ﹤0.01% | 2933 |
|
|
2023
Q4 | – | Sell |
-44
| Closed | -$492 | – | 3507 |
|
|
2023
Q3 | $492 | Buy |
44
+21
| +91% | +$235 | ﹤0.01% | 3047 |
|
|
2023
Q2 | $493 | Buy |
23
+13
| +130% | +$279 | ﹤0.01% | 2906 |
|
|
2023
Q1 | $405 | Buy |
+10
| New | +$405 | ﹤0.01% | 2880 |
|
|
2022
Q2 | – | Sell |
-5
| Closed | – | – | 2506 |
|
|
2022
Q1 | $0 | Buy |
+5
| New | – | ﹤0.01% | 2186 |
|
|
2017
Q1 | – | Sell |
-100
| Closed | -$3K | – | 775 |
|
|
2016
Q4 | $3K | Hold |
100
| – | – | ﹤0.01% | 534 |
|
|
2016
Q3 | $3K | Buy |
+100
| New | +$3K | ﹤0.01% | 561 |
|